TY - JOUR
KW - Digital therapeutics
KW - Behavioral interventions
KW - FDA authorization process
KW - Human
KW - Behavior Therapy
KW - Health Disparities
KW - Public Health
KW - Substance use disorder
KW - Digital Interventions
KW - Substance use treatment
KW - article
KW - 3383:Drug & Alcohol Rehabilitation
KW - 3233:Substance Abuse & Addiction
AU - Will M. Aklin
AU - Kevin M. Walton
AU - Patrick Antkowiak
A1 - 
AD - National Institute on Drug Abuse, Division of Therapeutics and Medical Consequences, Bethesda, MD, US aklinwm@mail.nih.gov; Food and Drug Administration, Center for Devices and Radiological Health, Office of Neurological and Physical Medicine Devices, MD, US ; Aklin, Will M.,3 White Flint North,Bethesda,US,20892,National Institute on Drug Abuse, National Institutes of Health,aklinwm@mail.nih.gov
BT - Drug and alcohol dependence
C5 - Education & Workforce; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
DO - 10.1016/j.drugalcdep.2021.109120
JF - Drug and alcohol dependence
LA - English
M1 - Journal Article
PY - 2021
SN - 0376-8716, 0376-8716
SP - 3
T1 - Digital therapeutics for Substance Use Disorders: Research priorities and clinical validation
T2 - Drug and alcohol dependence
TI - Digital therapeutics for Substance Use Disorders: Research priorities and clinical validation
U1 - Education & Workforce; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
U3 - 10.1016/j.drugalcdep.2021.109120
UR - https://www.proquest.com/scholarly-journals/digital-therapeutics-substance-use-disorders/docview/2629429765/se-2?accountid=28100
VL - 229
VO - 0376-8716, 0376-8716
Y1 - 2021
Y2 - Dec 01
ER -